← FDA Drug Approvals (Drugs@FDA)

ETOMIDATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-04-18

Drug application

FDA Application #

ANDA209058

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETOMIDATE

Generic name

ETOMIDATE INJECTION

Active ingredients

ETOMIDATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Fosun Pharma USA Inc

First approval

2017-04-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown